 Randall Wilkening
Concepts (277)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Sheep | 65 | 2023 | 760 | 1.270 |
Why?
| | Placenta | 38 | 2023 | 627 | 1.250 |
Why?
| | Fetus | 34 | 2023 | 697 | 1.130 |
Why?
| | Fetal Growth Retardation | 17 | 2023 | 470 | 0.820 |
Why?
| | Uterus | 18 | 2020 | 191 | 0.660 |
Why?
| | Amino Acids | 12 | 2023 | 443 | 0.620 |
Why?
| | Maternal-Fetal Exchange | 17 | 2013 | 151 | 0.580 |
Why?
| | Oxygen Consumption | 15 | 2004 | 568 | 0.570 |
Why?
| | Liver | 14 | 2020 | 1630 | 0.550 |
Why?
| | Oxygen | 16 | 2023 | 827 | 0.530 |
Why?
| | Placental Insufficiency | 7 | 2023 | 102 | 0.490 |
Why?
| | Pregnancy | 58 | 2023 | 5490 | 0.480 |
Why?
| | Fetal Blood | 18 | 2014 | 266 | 0.440 |
Why?
| | Fetal Hypoxia | 4 | 2017 | 49 | 0.400 |
Why?
| | Glucose | 14 | 2023 | 894 | 0.380 |
Why?
| | Pregnancy, Animal | 7 | 2006 | 52 | 0.370 |
Why?
| | Umbilical Cord | 10 | 2016 | 80 | 0.340 |
Why?
| | Hindlimb | 6 | 2017 | 123 | 0.330 |
Why?
| | Umbilical Arteries | 7 | 2005 | 41 | 0.300 |
Why?
| | Animals | 69 | 2023 | 31162 | 0.280 |
Why?
| | Pulmonary Circulation | 7 | 1991 | 400 | 0.250 |
Why?
| | Regional Blood Flow | 17 | 2005 | 407 | 0.250 |
Why?
| | Acidosis | 2 | 2020 | 85 | 0.230 |
Why?
| | Hypoxia | 4 | 2016 | 919 | 0.230 |
Why?
| | Umbilical Veins | 9 | 2001 | 57 | 0.220 |
Why?
| | RNA, Messenger | 5 | 2016 | 2507 | 0.200 |
Why?
| | Ethanol | 6 | 2004 | 532 | 0.180 |
Why?
| | Blood Glucose | 12 | 2014 | 1823 | 0.180 |
Why?
| | Female | 64 | 2023 | 59115 | 0.180 |
Why?
| | Organ Size | 12 | 2016 | 420 | 0.180 |
Why?
| | Protein Biosynthesis | 2 | 2017 | 375 | 0.170 |
Why?
| | Chorioamnionitis | 1 | 2020 | 36 | 0.170 |
Why?
| | Insulin | 8 | 2017 | 2076 | 0.170 |
Why?
| | Gestational Age | 13 | 2006 | 762 | 0.170 |
Why?
| | Lactates | 6 | 1993 | 77 | 0.160 |
Why?
| | Glucagon | 2 | 2016 | 92 | 0.160 |
Why?
| | Biological Transport | 10 | 2014 | 363 | 0.160 |
Why?
| | Vasodilation | 5 | 1991 | 414 | 0.150 |
Why?
| | Glutamic Acid | 6 | 2014 | 207 | 0.150 |
Why?
| | Phosphoenolpyruvate Carboxykinase (GTP) | 2 | 2016 | 31 | 0.150 |
Why?
| | Anemia | 2 | 2017 | 141 | 0.150 |
Why?
| | Gluconeogenesis | 3 | 2014 | 60 | 0.150 |
Why?
| | Lactic Acid | 9 | 2023 | 269 | 0.150 |
Why?
| | Umbilicus | 3 | 2013 | 14 | 0.140 |
Why?
| | Disease Models, Animal | 6 | 2020 | 3470 | 0.140 |
Why?
| | Carbohydrate Metabolism | 2 | 2010 | 48 | 0.140 |
Why?
| | Glutamine | 4 | 2023 | 90 | 0.130 |
Why?
| | Threonine | 3 | 2003 | 40 | 0.130 |
Why?
| | Muscle Proteins | 1 | 2017 | 206 | 0.130 |
Why?
| | Muscle, Skeletal | 3 | 2017 | 1417 | 0.130 |
Why?
| | Dexamethasone | 4 | 2003 | 303 | 0.120 |
Why?
| | Endocrine System Diseases | 1 | 2014 | 30 | 0.120 |
Why?
| | Blood Flow Velocity | 6 | 1999 | 374 | 0.120 |
Why?
| | Respiratory Therapy | 1 | 1993 | 19 | 0.110 |
Why?
| | Glycine | 3 | 2023 | 151 | 0.110 |
Why?
| | Macrophages | 1 | 2020 | 1233 | 0.110 |
Why?
| | Antipyrine | 2 | 1984 | 3 | 0.110 |
Why?
| | Leucine | 3 | 2001 | 102 | 0.110 |
Why?
| | Pancuronium | 2 | 1990 | 3 | 0.100 |
Why?
| | Hyperinsulinism | 1 | 1994 | 103 | 0.100 |
Why?
| | Hydrocortisone | 4 | 2020 | 267 | 0.100 |
Why?
| | Histamine | 2 | 1990 | 56 | 0.100 |
Why?
| | Streptococcus agalactiae | 1 | 1993 | 81 | 0.100 |
Why?
| | Selective Estrogen Receptor Modulators | 1 | 2012 | 26 | 0.100 |
Why?
| | Respiratory Distress Syndrome, Newborn | 1 | 1993 | 102 | 0.100 |
Why?
| | Persistent Fetal Circulation Syndrome | 1 | 1993 | 132 | 0.100 |
Why?
| | Swimming | 1 | 2012 | 44 | 0.100 |
Why?
| | Estrogen Receptor beta | 1 | 2012 | 33 | 0.100 |
Why?
| | Tryptophan Hydroxylase | 1 | 2012 | 52 | 0.100 |
Why?
| | Up-Regulation | 1 | 2014 | 794 | 0.100 |
Why?
| | Streptococcal Infections | 1 | 1993 | 127 | 0.100 |
Why?
| | Raphe Nuclei | 1 | 2012 | 108 | 0.090 |
Why?
| | Acid-Base Equilibrium | 3 | 2003 | 27 | 0.090 |
Why?
| | Hot Temperature | 5 | 2001 | 298 | 0.090 |
Why?
| | Islets of Langerhans | 1 | 2017 | 728 | 0.090 |
Why?
| | Antidepressive Agents | 1 | 2012 | 195 | 0.090 |
Why?
| | Lysine | 2 | 2003 | 240 | 0.090 |
Why?
| | Hypoglycemia | 1 | 2014 | 386 | 0.090 |
Why?
| | Carbohydrates | 1 | 2010 | 54 | 0.090 |
Why?
| | Receptors, Histamine H1 | 1 | 1990 | 3 | 0.090 |
Why?
| | Receptors, Histamine H2 | 1 | 1990 | 8 | 0.080 |
Why?
| | Inflammation | 1 | 2020 | 2444 | 0.080 |
Why?
| | Glycogen | 2 | 2016 | 50 | 0.080 |
Why?
| | Serine | 2 | 2023 | 124 | 0.080 |
Why?
| | Neuromuscular Junction | 1 | 1989 | 52 | 0.080 |
Why?
| | Diffusion | 4 | 1991 | 115 | 0.080 |
Why?
| | Adaptation, Physiological | 1 | 1992 | 465 | 0.080 |
Why?
| | Nerve Block | 1 | 1989 | 60 | 0.080 |
Why?
| | Nitric Oxide | 1 | 1993 | 814 | 0.080 |
Why?
| | Alanine | 3 | 2000 | 104 | 0.080 |
Why?
| | Hemoglobin A | 1 | 1988 | 21 | 0.080 |
Why?
| | Oxyhemoglobins | 1 | 1988 | 19 | 0.080 |
Why?
| | Reference Values | 4 | 1997 | 735 | 0.070 |
Why?
| | Hemodynamics | 3 | 1991 | 996 | 0.070 |
Why?
| | Insulin-Like Growth Factor I | 2 | 2006 | 280 | 0.070 |
Why?
| | Pelvis | 1 | 1988 | 89 | 0.070 |
Why?
| | Osmolar Concentration | 5 | 2004 | 163 | 0.070 |
Why?
| | Insulin-Like Growth Factor II | 1 | 2006 | 23 | 0.070 |
Why?
| | Insulin-Like Growth Factor Binding Proteins | 1 | 2006 | 26 | 0.070 |
Why?
| | Polymers | 1 | 2010 | 448 | 0.070 |
Why?
| | Glucocorticoids | 3 | 2001 | 520 | 0.070 |
Why?
| | Receptor, TIE-2 | 1 | 2005 | 12 | 0.060 |
Why?
| | Hemoglobins | 1 | 1988 | 303 | 0.060 |
Why?
| | Angiopoietin-1 | 1 | 2005 | 10 | 0.060 |
Why?
| | Angiopoietin-2 | 1 | 2005 | 11 | 0.060 |
Why?
| | Pulmonary Artery | 2 | 1988 | 1012 | 0.060 |
Why?
| | Vasodilator Agents | 1 | 1988 | 303 | 0.060 |
Why?
| | Models, Biological | 6 | 2005 | 1589 | 0.060 |
Why?
| | Microspheres | 3 | 1991 | 122 | 0.060 |
Why?
| | Placental Circulation | 2 | 2006 | 56 | 0.060 |
Why?
| | Cycloleucine | 1 | 2004 | 3 | 0.060 |
Why?
| | Blood Pressure | 6 | 2005 | 1521 | 0.050 |
Why?
| | Vascular Endothelial Growth Factor A | 2 | 2003 | 496 | 0.050 |
Why?
| | Pyruvates | 1 | 2023 | 20 | 0.050 |
Why?
| | Glutamate Dehydrogenase | 1 | 2003 | 3 | 0.050 |
Why?
| | Receptors, Vascular Endothelial Growth Factor | 1 | 2003 | 103 | 0.050 |
Why?
| | Sugar Alcohols | 1 | 2002 | 3 | 0.050 |
Why?
| | Receptors, Growth Factor | 1 | 2002 | 49 | 0.050 |
Why?
| | Endothelial Growth Factors | 1 | 2002 | 49 | 0.050 |
Why?
| | AMP-Activated Protein Kinases | 1 | 2023 | 170 | 0.050 |
Why?
| | Lymphokines | 1 | 2002 | 110 | 0.050 |
Why?
| | Receptors, Cell Surface | 1 | 2003 | 347 | 0.050 |
Why?
| | Lung | 3 | 1988 | 3497 | 0.050 |
Why?
| | Isoleucine | 1 | 2001 | 11 | 0.050 |
Why?
| | Liver Circulation | 2 | 2000 | 19 | 0.050 |
Why?
| | Histidine | 1 | 2001 | 57 | 0.040 |
Why?
| | Labor, Induced | 2 | 2001 | 31 | 0.040 |
Why?
| | Phenylalanine | 1 | 2001 | 57 | 0.040 |
Why?
| | Infant Care | 1 | 1981 | 42 | 0.040 |
Why?
| | Hydrogen-Ion Concentration | 2 | 1993 | 502 | 0.040 |
Why?
| | Valine | 1 | 2001 | 72 | 0.040 |
Why?
| | Labor, Obstetric | 1 | 2001 | 51 | 0.040 |
Why?
| | Nitric Oxide Synthase | 1 | 2001 | 209 | 0.040 |
Why?
| | Methionine | 1 | 2001 | 144 | 0.040 |
Why?
| | Infant, Low Birth Weight | 1 | 1981 | 124 | 0.040 |
Why?
| | Tryptophan | 1 | 2001 | 134 | 0.040 |
Why?
| | Placental Hormones | 1 | 1999 | 4 | 0.040 |
Why?
| | Norepinephrine | 1 | 2020 | 197 | 0.040 |
Why?
| | Indocyanine Green | 1 | 1999 | 12 | 0.040 |
Why?
| | Partial Pressure | 3 | 2006 | 28 | 0.040 |
Why?
| | Coloring Agents | 1 | 1999 | 71 | 0.040 |
Why?
| | Veins | 2 | 1991 | 55 | 0.040 |
Why?
| | Infusions, Intravenous | 3 | 2003 | 368 | 0.040 |
Why?
| | Carbon Dioxide | 4 | 1997 | 205 | 0.040 |
Why?
| | Lipopolysaccharides | 1 | 2020 | 802 | 0.030 |
Why?
| | Dose-Response Relationship, Drug | 2 | 2012 | 1822 | 0.030 |
Why?
| | Hypertension | 1 | 2005 | 1051 | 0.030 |
Why?
| | Body Temperature | 3 | 2006 | 176 | 0.030 |
Why?
| | Carbon Radioisotopes | 2 | 2014 | 35 | 0.030 |
Why?
| | Glucose-6-Phosphatase | 1 | 2016 | 31 | 0.030 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 3 | 2003 | 914 | 0.030 |
Why?
| | Proteins | 1 | 2002 | 890 | 0.030 |
Why?
| | Infant, Newborn | 4 | 1995 | 5032 | 0.030 |
Why?
| | Kinetics | 3 | 1996 | 1528 | 0.030 |
Why?
| | Hepatocytes | 1 | 2016 | 196 | 0.030 |
Why?
| | Sheep, Domestic | 1 | 2014 | 33 | 0.030 |
Why?
| | Immunity, Innate | 1 | 2020 | 716 | 0.030 |
Why?
| | Arteries | 2 | 1999 | 244 | 0.030 |
Why?
| | Down-Regulation | 1 | 2017 | 593 | 0.030 |
Why?
| | Glutamates | 1 | 1994 | 55 | 0.030 |
Why?
| | DNA, Complementary | 2 | 2005 | 254 | 0.030 |
Why?
| | Embryonic and Fetal Development | 3 | 2001 | 90 | 0.030 |
Why?
| | Immunohistochemistry | 2 | 2012 | 1604 | 0.030 |
Why?
| | Humans | 11 | 2023 | 113531 | 0.030 |
Why?
| | Bicarbonates | 1 | 1993 | 41 | 0.030 |
Why?
| | Body Weight | 2 | 1997 | 853 | 0.030 |
Why?
| | Time Factors | 2 | 1993 | 6032 | 0.030 |
Why?
| | In Situ Hybridization | 1 | 2012 | 285 | 0.020 |
Why?
| | Guinea Pigs | 1 | 1992 | 135 | 0.020 |
Why?
| | Blood-Brain Barrier | 1 | 2012 | 102 | 0.020 |
Why?
| | Cats | 1 | 1992 | 188 | 0.020 |
Why?
| | Horses | 1 | 1992 | 96 | 0.020 |
Why?
| | Heart Rate | 3 | 1990 | 705 | 0.020 |
Why?
| | Plasmids | 1 | 2012 | 334 | 0.020 |
Why?
| | Estrogen Receptor alpha | 1 | 2012 | 121 | 0.020 |
Why?
| | Gene Expression Regulation | 1 | 2020 | 2293 | 0.020 |
Why?
| | Constriction | 1 | 1991 | 43 | 0.020 |
Why?
| | Neurogenesis | 1 | 2012 | 98 | 0.020 |
Why?
| | Receptors, Androgen | 1 | 2012 | 131 | 0.020 |
Why?
| | Chronic Disease | 1 | 2017 | 1570 | 0.020 |
Why?
| | Biological Transport, Active | 2 | 2005 | 71 | 0.020 |
Why?
| | Platelet Activating Factor | 1 | 1991 | 69 | 0.020 |
Why?
| | Fever | 2 | 2003 | 266 | 0.020 |
Why?
| | Myo-Inositol-1-Phosphate Synthase | 1 | 2010 | 2 | 0.020 |
Why?
| | Mannose | 1 | 2010 | 21 | 0.020 |
Why?
| | Sorbitol | 1 | 2010 | 15 | 0.020 |
Why?
| | Rabbits | 1 | 1992 | 713 | 0.020 |
Why?
| | Inositol | 1 | 2010 | 23 | 0.020 |
Why?
| | Transcriptional Activation | 1 | 2012 | 331 | 0.020 |
Why?
| | Receptors, Progesterone | 1 | 2012 | 319 | 0.020 |
Why?
| | Vascular Resistance | 2 | 1988 | 337 | 0.020 |
Why?
| | Histamine H1 Antagonists | 1 | 1990 | 28 | 0.020 |
Why?
| | Fructose | 1 | 2010 | 100 | 0.020 |
Why?
| | Respiration, Artificial | 1 | 1993 | 536 | 0.020 |
Why?
| | Histamine H2 Antagonists | 1 | 1990 | 26 | 0.020 |
Why?
| | Adenylate Kinase | 1 | 2009 | 26 | 0.020 |
Why?
| | Amino Acids, Branched-Chain | 1 | 2009 | 31 | 0.020 |
Why?
| | Peptide Chain Initiation, Translational | 1 | 2009 | 38 | 0.020 |
Why?
| | Aorta, Abdominal | 1 | 1989 | 38 | 0.020 |
Why?
| | Mathematics | 2 | 1996 | 101 | 0.020 |
Why?
| | Iliac Vein | 1 | 1988 | 10 | 0.020 |
Why?
| | Hippocampus | 1 | 2012 | 688 | 0.020 |
Why?
| | Iliac Artery | 1 | 1988 | 43 | 0.020 |
Why?
| | Bradykinin | 1 | 1988 | 41 | 0.020 |
Why?
| | Algorithms | 1 | 2014 | 1462 | 0.020 |
Why?
| | Rats, Sprague-Dawley | 1 | 2012 | 2139 | 0.020 |
Why?
| | Acetylcholine | 1 | 1988 | 163 | 0.020 |
Why?
| | Tolazoline | 1 | 1986 | 3 | 0.020 |
Why?
| | Muscles | 1 | 1988 | 313 | 0.020 |
Why?
| | Heating | 1 | 2006 | 17 | 0.020 |
Why?
| | Respiration | 1 | 2006 | 168 | 0.020 |
Why?
| | Placentation | 1 | 2005 | 40 | 0.020 |
Why?
| | DNA | 1 | 2012 | 1331 | 0.020 |
Why?
| | Cell Line, Tumor | 1 | 2012 | 2690 | 0.020 |
Why?
| | Bone and Bones | 1 | 1988 | 275 | 0.020 |
Why?
| | Cell Proliferation | 1 | 2012 | 2164 | 0.020 |
Why?
| | Laser-Doppler Flowmetry | 1 | 2005 | 30 | 0.010 |
Why?
| | Pulsatile Flow | 1 | 2005 | 54 | 0.010 |
Why?
| | Signal Transduction | 2 | 2009 | 4439 | 0.010 |
Why?
| | Rats | 1 | 2012 | 4829 | 0.010 |
Why?
| | Length of Stay | 1 | 1989 | 963 | 0.010 |
Why?
| | Decarboxylation | 2 | 1994 | 3 | 0.010 |
Why?
| | 2-Aminoadipic Acid | 1 | 2003 | 8 | 0.010 |
Why?
| | Amino Acids, Essential | 1 | 2003 | 12 | 0.010 |
Why?
| | Skin | 1 | 1988 | 650 | 0.010 |
Why?
| | Metabolic Clearance Rate | 1 | 2003 | 103 | 0.010 |
Why?
| | Nuclease Protection Assays | 1 | 2003 | 4 | 0.010 |
Why?
| | Drinking | 1 | 2003 | 30 | 0.010 |
Why?
| | Oxidation-Reduction | 2 | 1983 | 912 | 0.010 |
Why?
| | Blotting, Northern | 1 | 2003 | 190 | 0.010 |
Why?
| | Respiratory Mechanics | 1 | 2003 | 57 | 0.010 |
Why?
| | Vascular Endothelial Growth Factor Receptor-2 | 1 | 2003 | 85 | 0.010 |
Why?
| | Enzyme Induction | 1 | 2003 | 81 | 0.010 |
Why?
| | Vascular Endothelial Growth Factor Receptor-1 | 1 | 2003 | 67 | 0.010 |
Why?
| | Male | 3 | 2017 | 55112 | 0.010 |
Why?
| | Sequence Homology, Nucleic Acid | 1 | 2003 | 147 | 0.010 |
Why?
| | Vascular Endothelial Growth Factors | 1 | 2002 | 61 | 0.010 |
Why?
| | Birth Weight | 2 | 1999 | 440 | 0.010 |
Why?
| | Species Specificity | 1 | 2002 | 531 | 0.010 |
Why?
| | Homeostasis | 1 | 1984 | 561 | 0.010 |
Why?
| | Nitric Oxide Synthase Type III | 1 | 2001 | 181 | 0.010 |
Why?
| | Fetal Weight | 1 | 2000 | 52 | 0.010 |
Why?
| | Carbon Isotopes | 1 | 2000 | 110 | 0.010 |
Why?
| | Placental Lactogen | 1 | 1999 | 20 | 0.010 |
Why?
| | Infant Nutritional Physiological Phenomena | 1 | 1981 | 133 | 0.010 |
Why?
| | Prolactin | 1 | 1999 | 93 | 0.010 |
Why?
| | Base Sequence | 1 | 2003 | 2080 | 0.010 |
Why?
| | Prenatal Care | 1 | 1981 | 250 | 0.010 |
Why?
| | Blotting, Western | 1 | 2001 | 1128 | 0.010 |
Why?
| | Molecular Sequence Data | 1 | 2003 | 2741 | 0.010 |
Why?
| | Progesterone | 1 | 1999 | 230 | 0.010 |
Why?
| | Trophoblasts | 1 | 1999 | 165 | 0.010 |
Why?
| | Phentolamine | 2 | 1987 | 13 | 0.010 |
Why?
| | Catheters, Indwelling | 1 | 1997 | 75 | 0.010 |
Why?
| | Keto Acids | 1 | 1996 | 12 | 0.010 |
Why?
| | Membrane Proteins | 1 | 2002 | 1008 | 0.010 |
Why?
| | Linear Models | 1 | 1997 | 767 | 0.010 |
Why?
| | Regression Analysis | 1 | 1996 | 932 | 0.010 |
Why?
| | Animals, Newborn | 1 | 1995 | 769 | 0.010 |
Why?
| | Meclofenamic Acid | 1 | 1991 | 4 | 0.010 |
Why?
| | Phospholipid Ethers | 1 | 1991 | 7 | 0.010 |
Why?
| | Medical Indigency | 1 | 1989 | 11 | 0.000 |
Why?
| | Adrenergic alpha-Antagonists | 1 | 1987 | 29 | 0.000 |
Why?
| | Infant, Newborn, Diseases | 1 | 1989 | 104 | 0.000 |
Why?
| | Perfusion | 1 | 1987 | 147 | 0.000 |
Why?
| | Humidity | 1 | 1987 | 35 | 0.000 |
Why?
| | Cimetidine | 1 | 1986 | 11 | 0.000 |
Why?
| | Verapamil | 1 | 1986 | 32 | 0.000 |
Why?
| | Diphenhydramine | 1 | 1986 | 30 | 0.000 |
Why?
| | Fetal Heart | 1 | 1986 | 37 | 0.000 |
Why?
| | Adult | 2 | 2002 | 30245 | 0.000 |
Why?
| | Ambulatory Care | 1 | 1989 | 480 | 0.000 |
Why?
| | Tritium | 1 | 1983 | 66 | 0.000 |
Why?
| | Patient Readmission | 1 | 1989 | 608 | 0.000 |
Why?
| | Organ Specificity | 1 | 1983 | 262 | 0.000 |
Why?
| | Patient Discharge | 1 | 1989 | 770 | 0.000 |
Why?
| | Fasting | 1 | 1983 | 242 | 0.000 |
Why?
|
|
Wilkening's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|